Durect Corp. (DRRX:NASDAQ) Annual Reports & Investor Relations Material

Overview

DURECT Corporation, a leading biopharmaceutical player, has made significant strides in the field of drug research and development. The company's focus on epigenetic regulation and pharmaceutical programs has led to the creation of innovative medicines that have the potential to revolutionize the industry. One of its main product lines is ALZET - a range of osmotic pumps and accessories used for research purposes in laboratory animals. DURECT is also known for its cutting-edge research into larsucosterol (DUR-928), an orally bioavailable small molecule that has already undergone a Phase IIb clinical trial. The drug has shown promising results in its ability to regulate lipid metabolism, stress and inflammatory responses, and cell death and survival. DUR-928 has the potential to address several critical medical crises, including alcohol-associated hepatitis and nonalcoholic steatohepatitis. The company also produces POSIMIR - a pain management product designed to deliver bupivacaine over three days in adult patients. Additionally, DURECT offers Methydur, which is designed to treat attention deficit hyperactivity disorder. DURECT markets and sells its ALZET products through a direct sales force in the United States, as well as through a network of distributors worldwide. The company has also forged strategic collaborations and other agreements with various entities, including Virginia Commonwealth University Intellectual Property Foundation, Indivior UK Ltd., and Innocoll Pharmaceuticals Limited. DURECT Corporation is headquartered in Cupertino, California and was founded in 1998. The company's commitment to research and development has made it a key player in the biopharmaceutical industry. With promising drug candidates in the pipeline, DURECT is poised to transform the healthcare landscape.

Frequently Asked Questions

What is Durect Corp.'s ticker?

Durect Corp.'s ticker is DRRX

What exchange is Durect Corp. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Durect Corp.'s headquarters?

They are based in Cupertino, California

How many employees does Durect Corp. have?

There are 51-200 employees working at Durect Corp.

What is Durect Corp.'s website?

It is http://www.durect.com

What type of sector is Durect Corp.?

Durect Corp. is in the Healthcare sector

What type of industry is Durect Corp.?

Durect Corp. is in the Drug Manufacturers - Other industry

Who are Durect Corp.'s peers and competitors?

The following five companies are Durect Corp.'s industry peers:

- Lannett Company

- N4 Pharma Plc

- Amryt Pharma plc

- Aurora Cannabis

- Venture Life Group Plc